Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease (ILD). Currently, two antifibrotic drugs are available for reducing forced vital capacity (FVC) decline in IPF. However, many pulmonologists wait before initiating treatment, especially when IPF pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Aono, Yuya, Nakamura, Yutaro, Kono, Masato, Nakamura, Hidenori, Yokomura, Koshi, Imokawa, Shiro, Toyoshima, Mikio, Yasui, Hideki, Hozumi, Hironao, Karayama, Masato, Suzuki, Yuzo, Furuhashi, Kazuki, Enomoto, Noriyuki, Fujisawa, Tomoyuki, Inui, Naoki, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495940/
https://www.ncbi.nlm.nih.gov/pubmed/32928050
http://dx.doi.org/10.1177/1753466620953783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495940/
https://www.ncbi.nlm.nih.gov/pubmed/32928050
http://dx.doi.org/10.1177/1753466620953783

Ejemplares similares